Technical Analysis for ATRC - AtriCure, Inc.

Grade Last Price % Change Price Change
grade B 32.645 -1.32% -0.44
ATRC closed up 0.61 percent on Wednesday, February 20, 2019, on approximately normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Earnings due: Feb 28

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ATRC trend table...

Date Alert Name Type % Chg
Feb 20 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.31%
Feb 20 Pocket Pivot Bullish Swing Setup -1.31%
Feb 20 Overbought Stochastic Strength -1.31%
Feb 19 Slingshot Bullish Bullish Swing Setup -0.71%
Feb 19 Upper Bollinger Band Walk Strength -0.71%
Feb 19 Overbought Stochastic Strength -0.71%
Feb 15 New Uptrend Bullish -1.64%
Feb 15 Doji - Bearish? Reversal -1.64%
Feb 15 Upper Bollinger Band Walk Strength -1.64%
Feb 15 Outside Day Range Expansion -1.64%

Older signals for ATRC ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
AtriCure, Inc., a medical device company, develops, manufactures, and sells cardiac surgical ablation systems designed to create precise lesions or scars in cardiac tissue. It provides isolator bipolar radio-frequency ablation clamps that are used for ablation during open-heart procedures; and ablation and sensing unit, a compact power generator that provides the radio-frequency (RF) energy for its clamps, multifunctional pens, and coolrail linear ablation devices. The company also offers AtriCure switch box, a compact switch box, which offers the technology needed for the dual pulsing electrodes in isolator synergy clamps; isolator multifunctional pens that enable surgeons to evaluate cardiac arrhythmias, as well as to perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and coolrail linear ablation device, a disposable linear RF ablation device that allows physicians to create an expanded cardiac ablation lesion set during minimally invasive procedures. In addition, it provides cryoablation system, which is used for AF ablation treatment during certain open-heart procedures; and AtriClip System that is designed to exclude the left atrial appendage by implanting the device during concomitant open surgical procedures. Further, the company sells technologies, including Lumitip dissector to separate tissues to provide access to anatomical structures that are targeted for ablation; and the MicroPace ORLab system, a stimulating, mapping, and recording system, which enables physicians to confirm that the ablation lines being created are forming electrical barriers or lines of block. The company sells its products to hospitals and medical centers through independent distributors and direct sales personnel worldwide. AtriCure, Inc. is headquartered in West Chester, Ohio.
Energy Medicine Medical Specialties Clinical Medicine Interventional Radiology Minimally Invasive Procedures Ablation Cardiac Arrhythmias Catheter Ablation
Is ATRC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 36.49
52 Week Low 17.26
Average Volume 202,569
200-Day Moving Average 30.0752
50-Day Moving Average 30.493
20-Day Moving Average 31.4315
10-Day Moving Average 32.241
Average True Range 1.0466
ADX 26.84
+DI 26.4911
-DI 14.6443
Chandelier Exit (Long, 3 ATRs ) 30.5002
Chandelier Exit (Short, 3 ATRs ) 32.5098
Upper Bollinger Band 33.6868
Lower Bollinger Band 29.1762
Percent B (%b) 0.87
BandWidth 14.350572
MACD Line 0.6843
MACD Signal Line 0.475
MACD Histogram 0.2093
Fundamentals Value
Market Cap 1.14 Billion
Num Shares 34.3 Million
EPS -1.02
Price-to-Earnings (P/E) Ratio -32.43
Price-to-Sales 4.44
Price-to-Book 4.57
PEG Ratio -1.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 35.02
Resistance 3 (R3) 34.84 34.02 34.69
Resistance 2 (R2) 34.02 33.53 34.11 34.58
Resistance 1 (R1) 33.55 33.22 33.79 33.73 34.48
Pivot Point 32.73 32.73 32.85 32.82 32.73
Support 1 (S1) 32.26 32.24 32.50 32.44 31.68
Support 2 (S2) 31.44 31.93 31.53 31.58
Support 3 (S3) 30.97 31.44 31.47
Support 4 (S4) 31.15